You have no items in your shopping cart.
Cart summary
SARS-CoV-2 Spike RBD Protein (K417N & E484K & N501Y, His), Biotinylated
Catalog Number: orb1953813
| Catalog Number | orb1953813 |
|---|---|
| Category | Proteins |
| Description | SARS-CoV-2 Spike RBD Protein (K417N & E484K & N501Y, His), Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.7 kDa and the accession number is A0A6G7K2L4. |
| Tag | C-His |
| Purity | 98.00% |
| MW | 26.7 kDa (predicted); 36 kDa (reducing condition, due to glycosylation) |
| UniProt ID | A0A6G7K2L4 |
| Expression System | HEK293 Cells |
| Biological Origin | SARS-CoV-2 |
| Biological Activity | SARS-CoV-2 Spike RBD Protein (K417N & E484K & N501Y, His), Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.7 kDa and the accession number is A0A6G7K2L4. |
| Expression Region | A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike RBD (YP_009724390.1, with mutations K417N, E484K, N501Y) (Arg319-Phe541) was expressed with a polyhistidine tag at the C-terminus. The purified protein was biotinylated in vitro. The mutations were identified in the SARS-CoV-2 variant (known as 20C/501Y.V2 or B.1.351 lineage) which emerged in South Africa. Predicted N terminal: Ser |
| Storage | -20°C |
| Note | For research use only |
| Application notes | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
| Expiration Date | 6 months from date of receipt. |
